Keuters, Meike Hedwig
Keksa-Goldsteine, Velta
Dhungana, Hiramani
Huuskonen, Mikko T.
Pomeshchik, Yuriy
Savchenko, Ekaterina
Korhonen, Paula K.
Singh, Yajuvinder
Wojciechowski, Sara
Lehtonen, Šárka
Kanninen, Katja M.
Malm, Tarja
Sirviö, Jouni
Muona, Anu
Koistinaho, Milla
Goldsteins, Gundars
Koistinaho, Jari
Funding for this research was provided by:
the European Commission Seventh Framework Programme (FP7) for Research and Technological Development (607962, 607962, 607962)
Article History
Received: 19 May 2020
Accepted: 11 January 2021
First Online: 10 February 2021
Competing interests
: AM, MK, GG and JK are shareholders of Aranda Pharma Ltd. MHK, VKG, HD, MTH,YP, ES, PKK, YS, SW, SL, KMK, and TM have no conflict of interest or any competing financial or non-financial interests in relation to the work to disclose. The authors confirm that they have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with the guidelines.